(Q54258830)

English

Cisplatin as second line chemotherapy in advanced or recurrent squamous cell carcinoma of head and neck region.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

title

Cisplatin as second line chemotherapy in advanced or recurrent squamous cell carcinoma of head and neck region. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

main subject

head and neck squamous cell carcinoma

1 reference

Keldsen N

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

publication date

1 January 1987

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

published in

Acta Oncologica

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

volume

26

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

page(s)

357-359

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

cites work

Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F02841868709104360

retrieved

21 January 2018

24-hour infusion of cis-platinum in head and neck cancers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F02841868709104360

retrieved

21 January 2018

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F02841868709104360

retrieved

21 January 2018

Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F02841868709104360

retrieved

21 January 2018

Identifiers

DOI

10.3109/02841868709104360

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

PubMed publication ID

3426847

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3426847

retrieved

26 May 2018

reference URL

http://europepmc.org/abstract/MED/3426847

ResearchGate publication ID

19729184

0 references

(Q54258830)

Cisplatin as second line chemotherapy in advanced or recurrent squamous cell carcinoma of head and neck region.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)